MapLight Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MPLT | NMRA | ANRO | DRUG | ATAI | ACAD | |
|---|---|---|---|---|---|---|
| Market cap | 372.91M | 106.35M | 914.34M | 187.02M | — | 3.70B |
| P/E (TTM) | — | — | — | — | — | 9.6 |
| Forward P/E | -2.0 | -0.9 | -7.3 | -3.5 | — | 23.3 |
| Price/book | 0.9 | 2.4 | 3.7 | 0.9 | — | 3.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −57.44% | −78.21% | +101.06% | −58.69% | — | −7.88% |
| Today | −1.47% | −0.86% | +2.64% | −12.02% | 0.00% | +4.38% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MPLT news ›Maplight Therapeutics (NASDAQ:MPLT) Stock Bumped Up to Sell by Wall Street Zen
Posted by Tristan Rich on Nov 1st, 2026 Wall Street Zen upgraded shares of Maplight Therapeutics (NASDAQ:MPLT – Free Report) from a strong sell rating to a sell rating in a research report sent to investors on Saturday,Wall Street Zen…
MapLight: 'Hold' Rating On ML-007C-MA In Schizophrenia And 2nd Half 2027 ADP Data Readout
MapLight Therapeutics gets a Hold as mixed-phase 2 schizophrenia data temper outlook. Click here to read my most recent analysis of MPLT stock. - I initiate MapLight Therapeutics with a "Hold" rating due to mixed phase 2 data for…
Therma Bright Seeks $420,000 in Discounted Private Placement to Fund Operations
An announcement from Therma Bright ( (TSE:THRM) ) is now available. Spark’s Take on THRM Stock According to Spark, TipRanks’ AI Analyst, THRM is a Neutral. The score is primarily held back by weak financial fundamentals (large ongoing…
MapLight Therapeutics to Participate in Upcoming Investor Conference
SAN FRANCISCO and BOSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its mana... MapLight Therapeutics to Participate in Upcoming Investor Conference SAN FRANCISCO and…
MapLight Therapeutics initiated with a Neutral at Guggenheim
Guggenheim initiated coverage of MapLight Therapeutics (MPLT) with a Neutral rating and no price target The company’s Phase 2 readout in July c... MapLight Therapeutics initiated with a Neutral at Guggenheim Guggenheim initiated coverage…
MapLight Therapeutics price target lowered to $43 from $45 at Needham
Needham lowered the firm’s price target on MapLight Therapeutics (MPLT) to $43 from $45 and keeps a Buy rating on the shares. The firm is updat... MapLight Therapeutics price target lowered to $43 from $45 at Needham Needham lowered the…
ConocoPhillips officer proposes $576K share sale
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing Bloom Energy Reports Record Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance WD Reports Fiscal First Quarter…
Applied Optoelectronics officer proposes $720K sale
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan Greenland Energy Company Announces the Resignation of Roderick McIllree From the Board of Directors BlackRock Capital Allocation Term Trust…
Disc Medicine shareholder proposes $6.54K stock sale
A proposed sale of 115 Disc Medicine (IRON) shares comes from Atlas Venture Fund XII. Stock Titan Disc Medicine shareholder proposes $6.54K stock sale Disc Medicine, Inc. (IRON) is the issuer in a Rule 144 notice from Atlas Venture Fund…
Maplight Therapeutics (NASDAQ:MPLT) CFO Sells $82,149.36 in Stock
Shares of NASDAQ MPLT opened at $7.70 on Monday. Maplight Therapeutics, Inc. has a 12-month low of $7.46 and a 12-month high of $40.43. The firm’s 50-day simple moving average is $11.24 and its 200 day simple moving average is $22.40. The…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net9
- defenseworld.net5
- markets.businessinsider.com4
- marketbeat.com2
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.